Jul 23, 2019 Oncolytics Biotech(R) Announces Preliminary AWARE-1 Trial Data Demonstrating Viral Replication and Promotion of Inflammation Following Systemic Administration of Pelareorep When Combined with Tecentriq(R)
Jun 5, 2019 Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer
Jun 5, 2019 Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA
May 29, 2019 Oncolytics Biotech(R) to Present at the 9th Annual LD Micro Invitational Investor Conference
May 16, 2019 Oncolytics Biotech (R) Publishes Abstract Highlighting Additional Biomarker Analyses at the 2019 American Society of Clinical Oncology Annual Meeting
May 3, 2019 Oncolytics Biotech(R) Announces Voting Results from the Annual General Meeting of Shareholders
May 3, 2019 Oncolytics Biotech (R) Reports 2019 First Quarter Financial Results and Operational Highlights
Apr 23, 2019 Oncolytics Biotech(R) to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
Apr 8, 2019 Oncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
